PerkinElmer

As a leader focused on improving Human and Environmental health, we are helping scientists, clinicians, and government agencies discover more effective diagnostics and therapies, and making sure that the food we eat and the air we breathe are safe from contaminants. Environmental Health Overview 
 At PerkinElmer, we’re taking action to ensure the quality of our environment. The ability to rapidly detect known and unknown contaminants in our food, water and air, or to monitor their quality consistently, is an important part of maintaining a healthy environment. Our systems and services help scientists understand all of these complexities and ensure compliance. From food safety to air & water quality, PerkinElmer transforms information into results that improve our health and safety today and our world tomorrow. Human Health Overview 
 PerkinElmer creates life science research and diagnostic instrumentation as well as informatics and diagnostic lab services—all to fight illness proactively, provide medical insight more accurately, and develop therapies more quickly. Specializing in drug discovery, therapeutic research, as well as newborn screening and diagnostics, we know that the vision of a healthy tomorrow begins with what we do today. The Company reported revenue of approximately $2.2 billion in 2013 and has approximately 7,600 employees serving customers in more than 150 countries. Perkin Elmer, Inc. is a component of the S&P 500 Index (PKI-NYSE). 


Company Growth (employees)
Type
Public
HQ
Waltham, US
Size (employees)
8,000 (est)
PerkinElmer is headquartered in Waltham, US

PerkinElmer Office Locations

PerkinElmer has an office in Waltham
Waltham, US (HQ)
940 Winter St

PerkinElmer Metrics

PerkinElmer Financial Metrics

Revenue (2016)

$2.1 b

Revenue growth (2015-16), %

(6%)

Net income (2016)

$234.3 m

Market capitalization (21-Mar-2017)

$6.3 b

Closing share price (21-Mar-2017)

$57.1

Cash (31-Dec-2016)

$359.3 m
PerkinElmer's current market capitalization is $6.3 b.
PerkinElmer's revenue was reported to be $2.1 b in FY, 2016 which is a 6.5% decrease from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

$2.2 b$2.2 b$2.3 b$2.1 b

Revenue growth, %

3%1%(6%)

Gross profit

$977 m$1 b$1 b

Gross profit Margin, %

45%45%45%

EBIT

$217.4 m$210.7 m$286.1 m

EBIT margin, %

10%9%13%

Pre tax profit

$153.3 m$169.6 m$244 m$244.1 m

Net Income

$167.2 m$157.8 m$212.4 m$234.3 m
FY, 2013FY, 2014FY, 2015FY, 2016

Cash

$173.2 m$174.8 m$237.9 m$359.3 m

Accounts Receivable

$470 m$470.6 m$439 m$425.6 m

Inventories

$288 m$246.8 m

Current Assets

$1 b$1.1 b$1 b$1.2 b

PP&E

$185.4 m$176.2 m$167 m$145.5 m

Goodwill

$2.1 b$2.3 b$2.3 b$2.2 b

Total Assets

$3.9 b$4.1 b$4.2 b$4.3 b

Accounts Payable

$167.2 m$174 m$152.7 m$168 m

Total Debt

$1 b$1 b

Current Liabilities

$602.8 m$597.3 m$561.5 m$603.4 m

Additional Paid-in Capital

$119.9 m$94.3 m$52.9 m$26.1 m

Retained Earnings

$1.7 b$1.8 b$2 b$2.1 b

Total Equity

$2 b$2 b$2.1 b$2.2 b

Debt to Equity Ratio

0.5 x0.5 x

Debt to Assets Ratio

0.2 x0.2 x

Financial Leverage

2 x2 x2 x2 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

$167.2 m$157.8 m$212.4 m$234.3 m

Depreciation and Amortization

$128.5 m$116.7 m$112 m$100 m

Accounts Receivable

($14 m)($17 m)$6.8 m($19 m)

Inventories

Accounts Payable

($1.8 m)$8.1 m($16.1 m)$30.7 m

Cash From Operating Activities

$158.6 m$281.6 m$287.1 m$350.6 m

Capital Expenditures

($39 m)($29.1 m)($29.6 m)($31.7 m)

Cash From Investing Activities

($1.2 m)($295.9 m)($100.9 m)($100.8 m)

Dividends Paid

($31.6 m)($31.6 m)($31.6 m)($30.8 m)

Cash From Financing Activities

($154.2 m)$30.9 m($107.1 m)($115 m)

Interest Paid

$39.9 m$30.3 m$31.7 m$30.7 m

Income Taxes Paid

$36.7 m$40.6 m$49.3 m$43.5 m

Free Cash Flow

$197.6 m$310.7 m$316.7 m$382.3 m

PerkinElmer Market Value History

PerkinElmer Median Salaries

Source: 48 public H-1B filings from PerkinElmer

PerkinElmer Online Presence

PerkinElmer Company Life

You may also be interested in